Perlegen Awarded NIH Biodefense Grant for Comparative Salmonella Sequencing | GenomeWeb

NEW YORK, Sept. 16 (GenomeWeb News) - Perlegen Sciences said today that it has received a biodefense award from the US National Institutes of Health to use its microarray technology to sequence the genomes of several strains of Salmonella. 

The company said it would compare the strains to discover "signature SNPs" that could be used to identify the source of Salmonella in an outbreak.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.